[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Global Biosimilars/follow-on-biologics Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

December 2018 | 128 pages | ID: G2C69E14600EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Scope of the Report:

This report studies the Biosimilars/follow-on-biologics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimilars/follow-on-biologics market by product type and applications/end industries.
Biosimilars or follow-on-biologics are the “copied” and licensed versions of those reference biologics that have undergone patent expiration. Biosimilars development and validation with reference biologics is a crucial aspect of the overall development process. 
The global Biosimilars/follow-on-biologics market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biosimilars/follow-on-biologics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers
  • Novartis (Sandoz)
  • Synthon Pharmaceuticals
  • Teva Pharmaceutical Industries
  • LG Life Sciences
  • Celltrion Biocon
  • Hospira
  • Merck Serono (Merck)
  • Biogen idec
  • Genentech (Roche)
Market Segment by Regions, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, UK, Russia and Italy)
  • Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • South America (Brazil, Argentina, Colombia)
  • Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
  • Human growth hormone
  • Erythropoietin
  • Monoclonal antibodies
  • Insulin
  • Interferon
  • Granulocyte-Colony Stimulating Factor
  • Others
Market Segment by Applications, can be divided into
  • Blood disorders
  • Oncology diseases
  • Chronic and autoimmune diseases
  • Growth hormone deficiencies
  • Others
1 BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET OVERVIEW

1.1 Product Overview and Scope of Biosimilars/follow-on-biologics
1.2 Classification of Biosimilars/follow-on-biologics by Types
  1.2.1 Global Biosimilars/follow-on-biologics Revenue Comparison by Types (2017-2023)
  1.2.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Types in 2017
  1.2.3 Human growth hormone
  1.2.4 Erythropoietin
  1.2.5 Monoclonal antibodies
  1.2.6 Insulin
  1.2.7 Interferon
  1.2.8 Granulocyte-Colony Stimulating Factor
  1.2.9 Others
1.3 Global Biosimilars/follow-on-biologics Market by Application
  1.3.1 Global Biosimilars/follow-on-biologics Market Size and Market Share Comparison by Applications (2013-2023)
  1.3.2 Blood disorders
  1.3.3 Oncology diseases
  1.3.4 Chronic and autoimmune diseases
  1.3.5 Growth hormone deficiencies
  1.3.6 Others
1.4 Global Biosimilars/follow-on-biologics Market by Regions
  1.4.1 Global Biosimilars/follow-on-biologics Market Size (Million USD) Comparison by Regions (2013-2023)
  1.4.1 North America (USA, Canada and Mexico) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
  1.4.4 South America (Brazil, Argentina, Colombia) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
  1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilars/follow-on-biologics Status and Prospect (2013-2023)
1.5 Global Market Size of Biosimilars/follow-on-biologics (2013-2023)

2 MANUFACTURERS PROFILES

2.1 Novartis (Sandoz)
  2.1.1 Business Overview
  2.1.2 Biosimilars/follow-on-biologics Type and Applications
    2.1.2.1 Product A
    2.1.2.2 Product B
  2.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Synthon Pharmaceuticals
  2.2.1 Business Overview
  2.2.2 Biosimilars/follow-on-biologics Type and Applications
    2.2.2.1 Product A
    2.2.2.2 Product B
  2.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Teva Pharmaceutical Industries
  2.3.1 Business Overview
  2.3.2 Biosimilars/follow-on-biologics Type and Applications
    2.3.2.1 Product A
    2.3.2.2 Product B
  2.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.4 LG Life Sciences
  2.4.1 Business Overview
  2.4.2 Biosimilars/follow-on-biologics Type and Applications
    2.4.2.1 Product A
    2.4.2.2 Product B
  2.4.3 LG Life Sciences Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.5 Celltrion Biocon
  2.5.1 Business Overview
  2.5.2 Biosimilars/follow-on-biologics Type and Applications
    2.5.2.1 Product A
    2.5.2.2 Product B
  2.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Hospira
  2.6.1 Business Overview
  2.6.2 Biosimilars/follow-on-biologics Type and Applications
    2.6.2.1 Product A
    2.6.2.2 Product B
  2.6.3 Hospira Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.7 Merck Serono (Merck)
  2.7.1 Business Overview
  2.7.2 Biosimilars/follow-on-biologics Type and Applications
    2.7.2.1 Product A
    2.7.2.2 Product B
  2.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.8 Biogen idec
  2.8.1 Business Overview
  2.8.2 Biosimilars/follow-on-biologics Type and Applications
    2.8.2.1 Product A
    2.8.2.2 Product B
  2.8.3 Biogen idec Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)
2.9 Genentech (Roche)
  2.9.1 Business Overview
  2.9.2 Biosimilars/follow-on-biologics Type and Applications
    2.9.2.1 Product A
    2.9.2.2 Product B
  2.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET COMPETITION, BY PLAYERS

3.1 Global Biosimilars/follow-on-biologics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
  3.2.1 Top 5 Biosimilars/follow-on-biologics Players Market Share
  3.2.2 Top 10 Biosimilars/follow-on-biologics Players Market Share
3.3 Market Competition Trend

4 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET SIZE BY REGIONS

4.1 Global Biosimilars/follow-on-biologics Revenue and Market Share by Regions
4.2 North America Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
4.3 Europe Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
4.5 South America Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA BIOSIMILARS/FOLLOW-ON-BIOLOGICS REVENUE BY COUNTRIES

5.1 North America Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
5.2 USA Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
5.3 Canada Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
5.4 Mexico Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)

6 EUROPE BIOSIMILARS/FOLLOW-ON-BIOLOGICS REVENUE BY COUNTRIES

6.1 Europe Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
6.2 Germany Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6.3 UK Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6.4 France Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6.5 Russia Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
6.6 Italy Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)

7 ASIA-PACIFIC BIOSIMILARS/FOLLOW-ON-BIOLOGICS REVENUE BY COUNTRIES

7.1 Asia-Pacific Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
7.2 China Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7.3 Japan Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7.4 Korea Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7.5 India Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)

8 SOUTH AMERICA BIOSIMILARS/FOLLOW-ON-BIOLOGICS REVENUE BY COUNTRIES

8.1 South America Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
8.2 Brazil Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
8.3 Argentina Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
8.4 Colombia Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)

9 MIDDLE EAST AND AFRICA REVENUE BIOSIMILARS/FOLLOW-ON-BIOLOGICS BY COUNTRIES

9.1 Middle East and Africa Biosimilars/follow-on-biologics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9.3 UAE Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9.4 Egypt Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)
9.6 South Africa Biosimilars/follow-on-biologics Revenue and Growth Rate (2013-2018)

10 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET SEGMENT BY TYPE

10.1 Global Biosimilars/follow-on-biologics Revenue and Market Share by Type (2013-2018)
10.2 Global Biosimilars/follow-on-biologics Market Forecast by Type (2018-2023)
10.3 Human growth hormone Revenue Growth Rate (2013-2023)
10.4 Erythropoietin Revenue Growth Rate (2013-2023)
10.5 Monoclonal antibodies Revenue Growth Rate (2013-2023)
10.6 Insulin Revenue Growth Rate (2013-2023)
10.7 Interferon Revenue Growth Rate (2013-2023)
10.8 Granulocyte-Colony Stimulating Factor Revenue Growth Rate (2013-2023)
10.9 Others Revenue Growth Rate (2013-2023)

11 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET SEGMENT BY APPLICATION

11.1 Global Biosimilars/follow-on-biologics Revenue Market Share by Application (2013-2018)
11.2 Biosimilars/follow-on-biologics Market Forecast by Application (2018-2023)
11.3 Blood disorders Revenue Growth (2013-2018)
11.4 Oncology diseases Revenue Growth (2013-2018)
11.5 Chronic and autoimmune diseases Revenue Growth (2013-2018)
11.6 Growth hormone deficiencies Revenue Growth (2013-2018)
11.7 Others Revenue Growth (2013-2018)

12 GLOBAL BIOSIMILARS/FOLLOW-ON-BIOLOGICS MARKET SIZE FORECAST (2018-2023)

12.1 Global Biosimilars/follow-on-biologics Market Size Forecast (2018-2023)
12.2 Global Biosimilars/follow-on-biologics Market Forecast by Regions (2018-2023)
12.3 North America Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
12.4 Europe Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
12.6 South America Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Biosimilars/follow-on-biologics Revenue Market Forecast (2018-2023)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Data Source
LIST OF TABLES AND FIGURES

Figure Biosimilars/follow-on-biologics Picture
Table Product Specifications of Biosimilars/follow-on-biologics
Table Global Biosimilars/follow-on-biologics and Revenue (Million USD) Market Split b

More Publications

Need Help?

Ask a Question

Market Reports

All Categories